Loading…
Covista Inc. is projected to rise to $143.66 by 2027, a +14% move from its current price of $126.44. CVSA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $122.90 | $126.48 | $130.16 | +0.03% |
| Aug 2 | $121.49 | $126.52 | $131.76 | +0.06% |
| Aug 3 | $120.43 | $126.56 | $133.00 | +0.09% |
| Aug 4 | $119.54 | $126.60 | $134.07 | +0.13% |
| Aug 5 | $118.77 | $126.64 | $135.02 | +0.16% |
| Aug 6 | $118.08 | $126.68 | $135.90 | +0.19% |
| Aug 7 | $117.46 | $126.72 | $136.71 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $117.46 | $126.72 | $136.71 | +0.22% |
| Week 2 | $114.07 | $126.99 | $141.38 | +0.44% |
| Week 3 | $111.60 | $127.27 | $145.15 | +0.66% |
| Week 4 | $109.59 | $127.55 | $148.45 | +0.88% |
| Week 5 | $107.88 | $127.83 | $151.47 | +1.10% |
| Week 6 | $106.38 | $128.11 | $154.28 | +1.32% |
| Week 7 | $105.04 | $128.39 | $156.93 | +1.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary.
The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice.
The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves.
Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois. It is categorized as Consumer Defensive.
Covista Inc. (CVSA) is currently priced at $126.30 and has a market cap of $4.3B, with a rank of 1434. Technical indicators show a bullish tilt, including RSI of 50, SMA50 of $124.00, and SMA200 of $114.13, with near-term support at $112.08 and resistance at $135.55. The stock’s 30-day price range spans $106.92 to $149.20.
The forecast horizon shows upside potential, with 2026 averaging $126.30 and rising through the years to 2030 averaging $256.40, 2040 averaging $717.35, and 2050 averaging $1,674.06. Max values climb to $366.92 by 2030, $1,183.10 by 2040, and $3,007.64 by 2050. Sentiment shifts from neutral in 2026 to bullish in subsequent years, reflecting a strong long-run upside potential.
A major floor 19.9% below — a decisive break under it would weaken the trend.
The nearest floor, 11.4% below — buyers have tended to step in here.
The nearest ceiling, 7.2% above — a clean break opens room to run.
A major ceiling 17.2% above — clearing it would confirm fresh momentum.
Key CVSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CVSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $124.48 | Buy | $125.30 | Buy |
| MA 10 | $119.90 | Buy | $123.24 | Buy |
| MA 20 | $124.22 | Buy | $123.06 | Buy |
| MA 50 | $123.92 | Buy | $122.55 | Buy |
| MA 100 | $119.28 | Buy | $119.92 | Buy |
| MA 200 | $113.75 | Buy | $116.87 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.43 | Neutral |
| Stoch RSI (14) | 67.28 | Neutral |
| CCI (20) | 20.20 | Neutral |
| Williams %R (14) | -33.27 | Info |
| MACD (12,26,9) | 0.89 | Buy |
| ROC (12) | -4.29 | Sell |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 66.73 | Neutral |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | 0.72 | Buy |
| Ultimate (7,14,28) | 58.26 | Neutral |
| Momentum (10) | 10.22 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 131.25 | Sell |
| ADX (14) | 16.76 | Neutral |
| ATR (14) | 3.67 | Info |
The near-term technical picture remains bullish, with the stock trading within a 30-day range of $106.92 to $149.20 and a current sentiment labeled as BULLISH. The RSI14 sits at 50, while the market sits above the SMA50 of $124.00 and above the SMA200 of $114.13, framing a constructive setup.
Near-term support is at $112.08 and resistance at $135.55, suggesting a defined trading range around recent price levels. As price action unfolds, traders may watch how the stock interacts with the $124.00 area near the SMA50 and the $135.55 resistance as catalysts for short-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $92.92 | $126.44 | $168.73 | 0% | Neutral | |
| $114.03 | $143.66 | $191.66 | +14% | Neutral | |
| $138.55 | $179.83 | $249.50 | +42% | Bullish | |
| $174.55 | $232.20 | $332.13 | +84% | Bullish | |
| $196.50 | $267.15 | $391.99 | +111% | Bullish | |
| $234.34 | $324.96 | $487.53 | +157% | Bullish | |
| $252.05 | $356.02 | $544.86 | +182% | Bullish | |
| $252.15 | $362.38 | $564.65 | +187% | Bullish | |
| $283.02 | $413.51 | $655.05 | +227% | Bullish | |
| $308.10 | $457.29 | $735.60 | +262% | Bullish | |
| $484.71 | $772.86 | $1,325.50 | +511% | Bullish | |
| $1,033.34 | $1,865.21 | $3,510.84 | +13.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $92.92 | $126.44 | $147.70 | +0.00% |
| August 2026 | $111.76 | $131.31 | $157.98 | +3.85% |
| September 2026 | $109.76 | $130.10 | $158.73 | -0.92% |
| October 2026 | $109.71 | $130.96 | $161.55 | +0.66% |
| November 2026 | $112.49 | $135.05 | $168.10 | +3.12% |
| December 2026 | $111.41 | $134.46 | $168.73 | -0.43% |
Click any year to see its month-by-month CVSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CVSA to range from $92.92 to $168.73 through 2026. The $126.44 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CVSA price prediction for 2027 points to an average of $143.66 (low $114.03, high $191.66) — a potential gain of +14% on today's $126.44. A consolidation phase looks the most probable path here.
In 2028, CVSA is projected to trade between $138.55 and $249.50, averaging $179.83 — a potential gain of +42% from today's $126.44. That is up +25% on the projected 2027 average. Momentum favours further upside here.
Covista Inc.'s 2029 outlook centres on $232.20, within a $174.55 to $332.13 range. That is up +29% on the projected 2028 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CVSA could reach as high as $391.99, with a base case around $267.15 and support toward $196.50 — roughly +111% from $126.44. Momentum favours further upside here.
Expect CVSA to range from $234.34 to $487.53 through 2031. The $324.96 average target implies a +157% move from current prices. That is up +22% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CVSA price prediction for 2032 points to an average of $356.02 (low $252.05, high $544.86) — a potential gain of +182% on today's $126.44. Momentum favours further upside here.
In 2033, CVSA is projected to trade between $252.15 and $564.65, averaging $362.38 — a potential gain of +187% from today's $126.44. That is up +2% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Covista Inc.'s 2034 outlook centres on $413.51, within a $283.02 to $655.05 range. That is up +14% on the projected 2033 average. That marks a +227% change versus current levels. Momentum favours further upside here.
By 2035, CVSA could reach as high as $735.60, with a base case around $457.29 and support toward $308.10 — roughly +262% from $126.44. Buyers look set to stay in control over this stretch.
Expect CVSA to range from $484.71 to $1,325.50 through 2040. The $772.86 average target implies a +511% move from current prices. That is up +69% on the projected 2035 average. Momentum favours further upside here.
The CVSA price prediction for 2050 points to an average of $1,865.21 (low $1,033.34, high $3,510.84) — a potential gain of +13.8x on today's $126.44. Buyers look set to stay in control over this stretch.
Investing $1,000 in CVSA today (≈ 7.90889 CVSA) could be worth
$14,751.74
+$13,751.74 (+1375%) by 2050 · US Dollar
Based on the average projected CVSA price of $1,865.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVSAwould be worth at today's price.
$1,000 invested in CVSA on Jul 30, 2025 (≈ 8.762706 CVSA) would be worth
$1,107.96
+$107.96 (+10.8%) today · 1.11× · US Dollar
Based on a CVSA entry price of $114.12 vs. today's $126.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $115.13 | $1,098.24 | +9.8% |
| 1 month ago | $124.66 | $1,014.28 | +1.4% |
| 3 months ago | $113.86 | $1,110.49 | +11.0% |
| 6 months ago | $103.55 | $1,221.05 | +22.1% |
| 1 year ago | $114.12 | $1,107.96 | +10.8% |
| All time (5.0y) ago | $36.64 | $3,450.87 | +245.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CVSA forecast.
Our base-case forecast reaches $250.00 around 2030.
Implied market cap at $250.00: $8.51B
The multi-year forecast shows sustained upside, with critical milestones highlighted across the horizon. In 2026 the min, avg, and max are $92.92, $126.30, and $166.52 respectively, with ROI of 0 and neutral sentiment. By 2027, the avg is $144.16 and ROI 14.1, with neutral sentiment continuing.
In 2028, the avg rises to $177.33 and max to $241.29, ROI of 40.4, and sentiment turns bullish.
By 2029 the avg is $223.31 with a max of $312.29 and ROI of 76.8, still described as bullish. In 2030 the min is $192.67, the avg $256.40, the max $366.92, with ROI 103 and bullish sentiment. The 2031–2035 window shows continuing gains: 2031 min $228.12, avg $308.80, max $450.86, ROI 144.5; 2032 min $245.20, avg $337.21, max $501.29, ROI 167; 2033 min $247.93, avg $346.07, max $522.92, ROI 174; 2034 min $277.20, avg $392.40, max $601.90, ROI 210.7; 2035 min $300.18, avg $430.68, max $669.91, ROI 241.
In 2040 the min rises to $470.54, the average to $717.35, and the max to $1,183.10, with ROI 468 and bullish sentiment. The long horizon culminates in 2050 with min $990.17, avg $1,674.06, max $3,007.64, ROI 1225.5 and bullish sentiment. These are estimates, not guarantees, and reflect the projected path under the stated assumptions.
Tap a question to reveal the answer.
The 2030 forecast shows min $192.67, avg $256.40, max $366.92, ROI 103, and sentiment bullish.
The forecast portfolio shows growing upside, with ROI values of 14.1% (2027), 40.4% (2028), 76.8% (2029), 103% (2030), 144.5% (2031), 167% (2032), 174% (2033), 210.7% (2034), 241% (2035), 468% (2040), and 1225.5% (2050); sentiment is neutral in 2026 and bullish in later years.
Yes. The 2040 forecast max is $1,183.10, while the average is $717.35, indicating the possibility of a price above $1,000 within the 2040 horizon.
Current price is $126.30 and market cap is $4.3B.
The 30-day range is $106.92 to $149.20. RSI14 is 50 with sentiment BULLISH, SMA50 is $124.00, SMA200 is $114.13, with near-term support at $112.08 and resistance at $135.55.
Covista Inc. Community Discussion
0Share your Covista Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.